If we have 2Bn SOI (current) and making 200M AUD a year just with this deal $2.00 could be a low price especially if costs are still less than 10M (currently 4M). As that would be 190M profit which they would use to reinvest (improve technology, marketing, buy tech? etc) but also could provide a dividend.
If they used 100M for dividends could be ~5c (current SOI) then you need to put a PE ratio on this too - REA 136 which would make us $6.80 if the same PE - WTC has PE of 139 which would make us $6.95 and XRO has PE of 4391 which would make us $219.55. These are all pretty extreme cases but go with a 'normal' tech stock and usually they are 35-45 which would be $1.75->$2.25 which would be right where you are talking.
However this is just Mineski potential, still got all the others which has already been announced plus the ones that are still to come (look at last 2 months and imagine 2 years!).
- Forums
- ASX - By Stock
- LU7
- Ann: Mineski Enters Strategic Partnership with Mogul
Ann: Mineski Enters Strategic Partnership with Mogul, page-38
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LU7 (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.7¢ |
Change
0.001(6.25%) |
Mkt cap ! $10.09M |
Open | High | Low | Value | Volume |
1.7¢ | 1.7¢ | 1.7¢ | $7.334K | 431.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1042530 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 106606 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1042530 | 0.016 |
6 | 1032233 | 0.015 |
6 | 509173 | 0.014 |
7 | 1443922 | 0.013 |
3 | 682500 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 106606 | 4 |
0.018 | 521530 | 4 |
0.019 | 2201904 | 2 |
0.020 | 1482273 | 5 |
0.021 | 550000 | 1 |
Last trade - 11.55am 15/07/2024 (20 minute delay) ? |
Featured News
LU7 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online